Concepts (436)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Dialysis | 30 | 2022 | 195 | 5.240 |
Why?
|
| Ascorbic Acid | 15 | 2020 | 50 | 3.480 |
Why?
|
| Kidney Failure, Chronic | 13 | 2020 | 205 | 2.550 |
Why?
|
| Ascorbic Acid Deficiency | 7 | 2014 | 7 | 1.940 |
Why?
|
| Hemoglobins | 6 | 2016 | 136 | 1.630 |
Why?
|
| Dialysis Solutions | 4 | 2015 | 7 | 1.210 |
Why?
|
| Anemia | 4 | 2011 | 128 | 1.010 |
Why?
|
| Chromatography, High Pressure Liquid | 19 | 2020 | 230 | 0.950 |
Why?
|
| Vitamins | 6 | 2023 | 79 | 0.830 |
Why?
|
| Oxidative Stress | 7 | 2003 | 304 | 0.780 |
Why?
|
| Carotenoids | 12 | 2006 | 68 | 0.750 |
Why?
|
| Dietary Supplements | 7 | 2023 | 239 | 0.740 |
Why?
|
| Macular Pigment | 1 | 2021 | 2 | 0.710 |
Why?
|
| Uremia | 3 | 2019 | 9 | 0.660 |
Why?
|
| Peritoneal Dialysis | 5 | 2012 | 13 | 0.650 |
Why?
|
| Antioxidants | 9 | 2006 | 256 | 0.630 |
Why?
|
| Indican | 2 | 2019 | 3 | 0.610 |
Why?
|
| Vitamin E | 13 | 2003 | 55 | 0.610 |
Why?
|
| Cardiovascular Diseases | 2 | 2023 | 848 | 0.570 |
Why?
|
| Humans | 80 | 2023 | 64238 | 0.540 |
Why?
|
| Toxins, Biological | 2 | 2016 | 6 | 0.510 |
Why?
|
| beta Carotene | 10 | 2001 | 67 | 0.510 |
Why?
|
| Dialysis | 1 | 2016 | 8 | 0.490 |
Why?
|
| Erythrocytes | 2 | 2016 | 150 | 0.490 |
Why?
|
| Hospitalization | 2 | 2014 | 1368 | 0.480 |
Why?
|
| Serum Albumin | 1 | 2016 | 46 | 0.480 |
Why?
|
| Iron | 3 | 2018 | 154 | 0.440 |
Why?
|
| Fatty Acids | 5 | 2009 | 202 | 0.430 |
Why?
|
| Membranes, Artificial | 1 | 2014 | 46 | 0.430 |
Why?
|
| Hyperoxaluria | 2 | 2020 | 10 | 0.420 |
Why?
|
| Oxalates | 3 | 2020 | 19 | 0.420 |
Why?
|
| Lipoproteins, LDL | 4 | 2004 | 46 | 0.420 |
Why?
|
| Vitamin A | 7 | 2001 | 28 | 0.410 |
Why?
|
| Fatigue | 3 | 2017 | 114 | 0.410 |
Why?
|
| Kidney Diseases | 3 | 2010 | 180 | 0.400 |
Why?
|
| DNA, Single-Stranded | 1 | 2014 | 107 | 0.400 |
Why?
|
| Hypercholesterolemia | 3 | 2004 | 70 | 0.370 |
Why?
|
| Hemodiafiltration | 2 | 2009 | 3 | 0.360 |
Why?
|
| Cholesterol, LDL | 4 | 2006 | 104 | 0.350 |
Why?
|
| Lutein | 7 | 2006 | 22 | 0.350 |
Why?
|
| Chromatography, Gas | 2 | 2009 | 8 | 0.340 |
Why?
|
| Insulin | 2 | 2009 | 684 | 0.340 |
Why?
|
| Dinoprost | 2 | 2001 | 19 | 0.340 |
Why?
|
| Erythrocyte Aging | 1 | 2010 | 2 | 0.330 |
Why?
|
| Cholesterol | 7 | 2006 | 260 | 0.330 |
Why?
|
| Malnutrition | 1 | 2011 | 41 | 0.330 |
Why?
|
| Diet | 6 | 2014 | 533 | 0.320 |
Why?
|
| Xanthophylls | 9 | 2009 | 26 | 0.320 |
Why?
|
| Male | 42 | 2022 | 30294 | 0.320 |
Why?
|
| Postprandial Period | 1 | 2009 | 19 | 0.310 |
Why?
|
| Hypochlorous Acid | 2 | 2000 | 3 | 0.310 |
Why?
|
| Salmon | 1 | 2009 | 8 | 0.310 |
Why?
|
| Animals, Domestic | 1 | 2009 | 15 | 0.300 |
Why?
|
| Animals, Wild | 1 | 2009 | 13 | 0.300 |
Why?
|
| Fingers | 1 | 2009 | 48 | 0.300 |
Why?
|
| Needles | 1 | 2009 | 70 | 0.300 |
Why?
|
| Breath Tests | 3 | 2003 | 14 | 0.290 |
Why?
|
| Eating | 1 | 2009 | 139 | 0.290 |
Why?
|
| Chronic Kidney Disease-Mineral and Bone Disorder | 1 | 2008 | 5 | 0.280 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2008 | 6 | 0.280 |
Why?
|
| Sodium, Dietary | 1 | 2007 | 9 | 0.270 |
Why?
|
| Ferric Compounds | 1 | 2007 | 44 | 0.270 |
Why?
|
| Middle Aged | 27 | 2019 | 17898 | 0.270 |
Why?
|
| Sodium | 1 | 2007 | 61 | 0.270 |
Why?
|
| DNA, Bacterial | 1 | 2009 | 268 | 0.260 |
Why?
|
| Macula Lutea | 5 | 2006 | 22 | 0.260 |
Why?
|
| Water | 1 | 2009 | 314 | 0.260 |
Why?
|
| Blood Glucose | 1 | 2009 | 486 | 0.260 |
Why?
|
| Renal Replacement Therapy | 1 | 2006 | 23 | 0.250 |
Why?
|
| Female | 30 | 2022 | 33350 | 0.240 |
Why?
|
| Ethane | 2 | 2003 | 2 | 0.240 |
Why?
|
| Vitamin B Complex | 1 | 2006 | 15 | 0.240 |
Why?
|
| Carnitine | 1 | 2006 | 20 | 0.240 |
Why?
|
| Reactive Oxygen Species | 3 | 2003 | 237 | 0.240 |
Why?
|
| Cresols | 2 | 2019 | 5 | 0.240 |
Why?
|
| Sulfuric Acid Esters | 2 | 2019 | 6 | 0.240 |
Why?
|
| Aged | 18 | 2023 | 14648 | 0.230 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 4 | 2001 | 41 | 0.230 |
Why?
|
| Hypotension | 1 | 2006 | 50 | 0.230 |
Why?
|
| Kinetics | 9 | 2018 | 766 | 0.220 |
Why?
|
| Dietary Fats | 2 | 2004 | 175 | 0.210 |
Why?
|
| Erythropoietin | 3 | 2010 | 40 | 0.210 |
Why?
|
| Adipose Tissue | 3 | 2009 | 296 | 0.210 |
Why?
|
| Cholesterol, HDL | 3 | 2006 | 72 | 0.200 |
Why?
|
| Cross-Sectional Studies | 5 | 2017 | 2616 | 0.200 |
Why?
|
| Diuretics | 1 | 2023 | 59 | 0.200 |
Why?
|
| Protein Binding | 3 | 2019 | 1618 | 0.200 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2022 | 147 | 0.200 |
Why?
|
| Adult | 22 | 2019 | 17116 | 0.190 |
Why?
|
| Egg Yolk | 3 | 2006 | 7 | 0.190 |
Why?
|
| In Vitro Techniques | 4 | 2016 | 490 | 0.190 |
Why?
|
| Amino Acids | 2 | 2000 | 148 | 0.180 |
Why?
|
| Hypertension | 1 | 2007 | 593 | 0.180 |
Why?
|
| Oxidation-Reduction | 9 | 2000 | 327 | 0.180 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2001 | 20 | 0.180 |
Why?
|
| CD36 Antigens | 1 | 2021 | 27 | 0.180 |
Why?
|
| Child | 5 | 2021 | 4583 | 0.170 |
Why?
|
| Analytic Sample Preparation Methods | 1 | 2020 | 4 | 0.160 |
Why?
|
| Lipid Peroxides | 2 | 1999 | 11 | 0.160 |
Why?
|
| Nucleoside Diphosphate Sugars | 1 | 2020 | 2 | 0.160 |
Why?
|
| Chromatography, Reverse-Phase | 1 | 2020 | 5 | 0.160 |
Why?
|
| Lysine | 1 | 2000 | 87 | 0.160 |
Why?
|
| Acute Kidney Injury | 2 | 2012 | 142 | 0.160 |
Why?
|
| Oligopeptides | 1 | 2000 | 135 | 0.160 |
Why?
|
| Free Radical Scavengers | 1 | 1999 | 21 | 0.160 |
Why?
|
| Avena | 1 | 1999 | 7 | 0.160 |
Why?
|
| Plants, Toxic | 2 | 1996 | 13 | 0.150 |
Why?
|
| Cognition | 1 | 2023 | 491 | 0.150 |
Why?
|
| Anemia, Iron-Deficiency | 2 | 2010 | 23 | 0.150 |
Why?
|
| Smoke | 2 | 1996 | 24 | 0.150 |
Why?
|
| Binding, Competitive | 2 | 2019 | 98 | 0.150 |
Why?
|
| Serum Albumin, Human | 1 | 2019 | 7 | 0.150 |
Why?
|
| Ibuprofen | 1 | 2019 | 17 | 0.150 |
Why?
|
| Smoking | 3 | 2001 | 861 | 0.150 |
Why?
|
| Diabetes Mellitus | 2 | 2003 | 541 | 0.150 |
Why?
|
| Diphosphates | 1 | 2018 | 12 | 0.150 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 497 | 0.150 |
Why?
|
| Animals | 20 | 2020 | 20961 | 0.140 |
Why?
|
| Citric Acid | 1 | 2018 | 20 | 0.140 |
Why?
|
| Polysaccharides | 1 | 2020 | 151 | 0.140 |
Why?
|
| Retina | 6 | 1992 | 126 | 0.140 |
Why?
|
| Transferrin | 1 | 2018 | 70 | 0.140 |
Why?
|
| Kynurenine | 1 | 2017 | 7 | 0.130 |
Why?
|
| Leg | 2 | 2022 | 87 | 0.130 |
Why?
|
| Chronic Disease | 3 | 2010 | 756 | 0.130 |
Why?
|
| Inflammation | 4 | 2009 | 1162 | 0.130 |
Why?
|
| Treatment Outcome | 6 | 2019 | 5691 | 0.130 |
Why?
|
| Tryptophan | 1 | 2017 | 56 | 0.130 |
Why?
|
| Eggs | 2 | 2006 | 10 | 0.130 |
Why?
|
| Lipids | 4 | 2006 | 319 | 0.130 |
Why?
|
| Erythropoiesis | 2 | 2006 | 37 | 0.120 |
Why?
|
| Zeaxanthins | 7 | 2006 | 14 | 0.120 |
Why?
|
| Electric Impedance | 2 | 2022 | 36 | 0.120 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 870 | 0.120 |
Why?
|
| Diabetes Complications | 2 | 2014 | 106 | 0.120 |
Why?
|
| Albumins | 1 | 2015 | 37 | 0.110 |
Why?
|
| Retinal Pigments | 3 | 1991 | 5 | 0.110 |
Why?
|
| Recombinant Proteins | 2 | 2008 | 704 | 0.110 |
Why?
|
| Prospective Studies | 3 | 2019 | 3315 | 0.110 |
Why?
|
| Heart Failure | 1 | 2022 | 926 | 0.110 |
Why?
|
| Sleep | 1 | 2017 | 231 | 0.100 |
Why?
|
| Aged, 80 and over | 4 | 2014 | 5520 | 0.100 |
Why?
|
| Cattle | 3 | 2007 | 316 | 0.100 |
Why?
|
| Case-Control Studies | 3 | 2017 | 1130 | 0.100 |
Why?
|
| C-Reactive Protein | 3 | 2003 | 166 | 0.100 |
Why?
|
| Nutritional Status | 4 | 2009 | 99 | 0.100 |
Why?
|
| Reference Standards | 4 | 2009 | 74 | 0.100 |
Why?
|
| Prognosis | 2 | 2008 | 1769 | 0.100 |
Why?
|
| Stereoisomerism | 4 | 2009 | 70 | 0.090 |
Why?
|
| Muscles | 2 | 2009 | 179 | 0.090 |
Why?
|
| F2-Isoprostanes | 2 | 2001 | 5 | 0.090 |
Why?
|
| Hospital Administration | 1 | 2012 | 43 | 0.090 |
Why?
|
| Cultural Competency | 1 | 2011 | 55 | 0.090 |
Why?
|
| Dielectric Spectroscopy | 1 | 2011 | 3 | 0.090 |
Why?
|
| Body Water | 1 | 2011 | 15 | 0.090 |
Why?
|
| Selenium | 2 | 1989 | 25 | 0.090 |
Why?
|
| Developing Countries | 1 | 2012 | 94 | 0.090 |
Why?
|
| Mass Spectrometry | 3 | 2000 | 303 | 0.090 |
Why?
|
| Age Factors | 2 | 2014 | 1569 | 0.090 |
Why?
|
| beta 2-Microglobulin | 1 | 2011 | 49 | 0.090 |
Why?
|
| Health Resources | 1 | 2012 | 94 | 0.090 |
Why?
|
| Risk Factors | 4 | 2013 | 5339 | 0.090 |
Why?
|
| Program Development | 1 | 2012 | 207 | 0.080 |
Why?
|
| Nutrition Policy | 1 | 2011 | 39 | 0.080 |
Why?
|
| Phosphatidylserines | 1 | 2010 | 13 | 0.080 |
Why?
|
| Community Health Services | 1 | 2011 | 127 | 0.080 |
Why?
|
| alpha-Tocopherol | 3 | 2004 | 18 | 0.080 |
Why?
|
| Fruit | 2 | 2001 | 110 | 0.080 |
Why?
|
| Depression | 1 | 2017 | 909 | 0.080 |
Why?
|
| Glycemic Index | 1 | 2009 | 23 | 0.080 |
Why?
|
| Capillaries | 1 | 2009 | 31 | 0.080 |
Why?
|
| Spectrophotometry, Ultraviolet | 2 | 2000 | 46 | 0.080 |
Why?
|
| Time Factors | 4 | 2019 | 3724 | 0.080 |
Why?
|
| Filtration | 1 | 2009 | 20 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 2478 | 0.070 |
Why?
|
| Water Purification | 1 | 2009 | 9 | 0.070 |
Why?
|
| Phagocytosis | 1 | 2010 | 266 | 0.070 |
Why?
|
| Rats | 5 | 2007 | 2005 | 0.070 |
Why?
|
| Triglycerides | 4 | 2006 | 244 | 0.070 |
Why?
|
| Survival Analysis | 2 | 2008 | 587 | 0.070 |
Why?
|
| Linoleic Acid | 2 | 2004 | 19 | 0.070 |
Why?
|
| Reproducibility of Results | 4 | 2017 | 1681 | 0.070 |
Why?
|
| Body Composition | 1 | 2009 | 153 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 458 | 0.070 |
Why?
|
| Epoetin Alfa | 1 | 2008 | 2 | 0.070 |
Why?
|
| Hematinics | 1 | 2008 | 11 | 0.070 |
Why?
|
| Analysis of Variance | 2 | 2008 | 607 | 0.070 |
Why?
|
| Parathyroid Hormone | 1 | 2008 | 44 | 0.070 |
Why?
|
| Glucaric Acid | 1 | 2007 | 2 | 0.070 |
Why?
|
| Biopsy, Needle | 1 | 1988 | 138 | 0.070 |
Why?
|
| Probability | 1 | 2008 | 169 | 0.070 |
Why?
|
| Injections, Intravenous | 1 | 2007 | 156 | 0.070 |
Why?
|
| Sex Distribution | 1 | 2008 | 251 | 0.070 |
Why?
|
| Age Distribution | 1 | 2008 | 258 | 0.070 |
Why?
|
| Glycosaminoglycans | 1 | 2007 | 20 | 0.070 |
Why?
|
| Hematopoiesis | 1 | 2007 | 125 | 0.070 |
Why?
|
| Drug Interactions | 1 | 2007 | 126 | 0.070 |
Why?
|
| Health Promotion | 1 | 2011 | 505 | 0.070 |
Why?
|
| Hemodialysis Solutions | 1 | 2006 | 2 | 0.060 |
Why?
|
| Linear Models | 1 | 2008 | 407 | 0.060 |
Why?
|
| Long-Term Care | 1 | 2008 | 177 | 0.060 |
Why?
|
| Calcium, Dietary | 1 | 2006 | 29 | 0.060 |
Why?
|
| Cholesterol Esters | 3 | 2004 | 10 | 0.060 |
Why?
|
| Thioctic Acid | 2 | 1997 | 7 | 0.060 |
Why?
|
| Oral Health | 1 | 2006 | 63 | 0.060 |
Why?
|
| Indicator Dilution Techniques | 2 | 1997 | 3 | 0.060 |
Why?
|
| Heart Diseases | 1 | 2008 | 220 | 0.060 |
Why?
|
| Lipid Peroxidation | 3 | 2001 | 65 | 0.060 |
Why?
|
| Indicators and Reagents | 2 | 1998 | 53 | 0.060 |
Why?
|
| Body Temperature | 1 | 2005 | 45 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 1999 | 869 | 0.060 |
Why?
|
| Liver | 3 | 1998 | 868 | 0.060 |
Why?
|
| Drug Resistance | 1 | 2006 | 155 | 0.050 |
Why?
|
| Oleic Acid | 1 | 2004 | 21 | 0.050 |
Why?
|
| Arteriosclerosis | 1 | 2004 | 32 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2011 | 706 | 0.050 |
Why?
|
| Aging | 4 | 2006 | 754 | 0.050 |
Why?
|
| Incidence | 1 | 2008 | 1383 | 0.050 |
Why?
|
| Aortic Diseases | 1 | 2004 | 65 | 0.050 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2004 | 48 | 0.050 |
Why?
|
| Croton Oil | 1 | 2003 | 1 | 0.050 |
Why?
|
| Plant Oils | 2 | 2004 | 60 | 0.050 |
Why?
|
| Calcium | 1 | 2006 | 580 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2008 | 2046 | 0.050 |
Why?
|
| Oxidants | 2 | 2000 | 19 | 0.050 |
Why?
|
| Arginine | 1 | 2003 | 131 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 1561 | 0.050 |
Why?
|
| Vegetables | 2 | 2001 | 69 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2003 | 1102 | 0.050 |
Why?
|
| Lung Neoplasms | 2 | 2001 | 695 | 0.050 |
Why?
|
| Esterification | 2 | 2001 | 4 | 0.050 |
Why?
|
| Water-Electrolyte Balance | 1 | 2022 | 15 | 0.050 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2003 | 45 | 0.050 |
Why?
|
| Energy Metabolism | 1 | 2005 | 384 | 0.050 |
Why?
|
| Tanzania | 2 | 2012 | 39 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2006 | 462 | 0.050 |
Why?
|
| Skin | 1 | 2005 | 385 | 0.050 |
Why?
|
| Infant | 2 | 2020 | 1664 | 0.050 |
Why?
|
| Acute-Phase Reaction | 1 | 2001 | 18 | 0.050 |
Why?
|
| Food, Organic | 1 | 2001 | 4 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2006 | 788 | 0.040 |
Why?
|
| Diet, Fat-Restricted | 1 | 2001 | 33 | 0.040 |
Why?
|
| Spectrophotometry | 2 | 1992 | 34 | 0.040 |
Why?
|
| Isomerism | 2 | 2020 | 28 | 0.040 |
Why?
|
| Cholesterol, Dietary | 1 | 2001 | 29 | 0.040 |
Why?
|
| Models, Biological | 1 | 2006 | 1187 | 0.040 |
Why?
|
| Glutathione | 2 | 1998 | 56 | 0.040 |
Why?
|
| Deuterium | 3 | 1998 | 24 | 0.040 |
Why?
|
| Diterpenes | 3 | 1998 | 21 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2013 | 6726 | 0.040 |
Why?
|
| Acetylation | 1 | 2000 | 123 | 0.040 |
Why?
|
| Pentanes | 1 | 2000 | 4 | 0.040 |
Why?
|
| Cricetulus | 1 | 2020 | 100 | 0.040 |
Why?
|
| Butylated Hydroxytoluene | 1 | 1999 | 4 | 0.040 |
Why?
|
| Hypersensitivity, Delayed | 1 | 1999 | 19 | 0.040 |
Why?
|
| Membrane Fluidity | 1 | 1999 | 15 | 0.040 |
Why?
|
| Glycosylation | 1 | 2020 | 138 | 0.040 |
Why?
|
| gamma-Linolenic Acid | 1 | 1999 | 16 | 0.040 |
Why?
|
| CHO Cells | 1 | 2020 | 189 | 0.040 |
Why?
|
| Cytokines | 1 | 2004 | 944 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2000 | 296 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2017 | 872 | 0.040 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2019 | 13 | 0.040 |
Why?
|
| Macular Degeneration | 1 | 2001 | 187 | 0.040 |
Why?
|
| Cryptoxanthins | 2 | 1996 | 2 | 0.040 |
Why?
|
| Vitamin A Deficiency | 1 | 1998 | 3 | 0.040 |
Why?
|
| Phenylhydrazines | 1 | 1998 | 1 | 0.040 |
Why?
|
| Sulfhydryl Reagents | 1 | 1998 | 1 | 0.040 |
Why?
|
| Diamide | 1 | 1998 | 6 | 0.040 |
Why?
|
| Trypsin | 1 | 1998 | 42 | 0.040 |
Why?
|
| Ligases | 1 | 1998 | 28 | 0.030 |
Why?
|
| Ubiquitins | 1 | 1998 | 41 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1998 | 190 | 0.030 |
Why?
|
| Plant Extracts | 1 | 1999 | 174 | 0.030 |
Why?
|
| Hydrolysis | 1 | 1998 | 147 | 0.030 |
Why?
|
| Aqueous Humor | 1 | 1997 | 4 | 0.030 |
Why?
|
| Lens, Crystalline | 1 | 1997 | 16 | 0.030 |
Why?
|
| Biomarkers | 2 | 2000 | 1431 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2018 | 436 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2000 | 1162 | 0.030 |
Why?
|
| NADP | 1 | 1997 | 22 | 0.030 |
Why?
|
| Exercise | 3 | 2011 | 954 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 1998 | 1997 | 0.030 |
Why?
|
| NAD | 1 | 1997 | 52 | 0.030 |
Why?
|
| Binding Sites | 1 | 2018 | 914 | 0.030 |
Why?
|
| Cricetinae | 3 | 2004 | 368 | 0.030 |
Why?
|
| Cytosol | 1 | 1997 | 181 | 0.030 |
Why?
|
| Administration, Oral | 4 | 1997 | 374 | 0.030 |
Why?
|
| Free Radicals | 2 | 1995 | 19 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2001 | 1272 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2020 | 2018 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 1998 | 1597 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2018 | 1159 | 0.030 |
Why?
|
| Saimiri | 2 | 1991 | 11 | 0.030 |
Why?
|
| Densitometry | 2 | 1991 | 13 | 0.030 |
Why?
|
| Macaca fascicularis | 2 | 1991 | 48 | 0.030 |
Why?
|
| Mesocricetus | 2 | 2004 | 94 | 0.030 |
Why?
|
| Mitochondria | 1 | 1997 | 384 | 0.020 |
Why?
|
| Physical Exertion | 1 | 1992 | 81 | 0.020 |
Why?
|
| Chromobacterium | 1 | 1992 | 1 | 0.020 |
Why?
|
| Pseudomonas | 1 | 1992 | 7 | 0.020 |
Why?
|
| Sterol Esterase | 1 | 1992 | 6 | 0.020 |
Why?
|
| Postmortem Changes | 1 | 1992 | 12 | 0.020 |
Why?
|
| Haplorhini | 1 | 1992 | 14 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 2 | 1989 | 92 | 0.020 |
Why?
|
| Solvents | 1 | 1992 | 58 | 0.020 |
Why?
|
| Kidneys, Artificial | 1 | 2011 | 1 | 0.020 |
Why?
|
| Lipase | 1 | 1992 | 52 | 0.020 |
Why?
|
| Charcoal | 1 | 2011 | 6 | 0.020 |
Why?
|
| Tissue Preservation | 1 | 1991 | 5 | 0.020 |
Why?
|
| Fixatives | 1 | 1991 | 16 | 0.020 |
Why?
|
| Adsorption | 1 | 2011 | 86 | 0.020 |
Why?
|
| Sodium Hypochlorite | 1 | 1991 | 12 | 0.020 |
Why?
|
| Chemistry | 2 | 1988 | 31 | 0.020 |
Why?
|
| Biotechnology | 1 | 2011 | 45 | 0.020 |
Why?
|
| Chemical Phenomena | 2 | 1988 | 96 | 0.020 |
Why?
|
| Interleukin-1 | 2 | 2003 | 156 | 0.020 |
Why?
|
| Neoplasms | 1 | 2001 | 1392 | 0.020 |
Why?
|
| Hemochromatosis | 1 | 1990 | 7 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 1990 | 17 | 0.020 |
Why?
|
| Ferritins | 1 | 1990 | 31 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 1990 | 96 | 0.020 |
Why?
|
| Genes | 1 | 1990 | 90 | 0.020 |
Why?
|
| Life Style | 1 | 2011 | 317 | 0.020 |
Why?
|
| Poverty | 1 | 2011 | 299 | 0.020 |
Why?
|
| Weight Loss | 1 | 2011 | 273 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2011 | 788 | 0.020 |
Why?
|
| Arm | 1 | 2009 | 46 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 2737 | 0.020 |
Why?
|
| Potassium | 1 | 2009 | 100 | 0.020 |
Why?
|
| Linoleic Acids | 1 | 1988 | 9 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2011 | 409 | 0.020 |
Why?
|
| Health Behavior | 1 | 2011 | 474 | 0.020 |
Why?
|
| Kidney | 2 | 2003 | 455 | 0.020 |
Why?
|
| Epidemiologic Factors | 1 | 2007 | 4 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1988 | 296 | 0.020 |
Why?
|
| Adolescent | 3 | 2012 | 6304 | 0.020 |
Why?
|
| Lipoproteins | 1 | 2007 | 84 | 0.020 |
Why?
|
| Photometry | 1 | 2006 | 7 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2007 | 141 | 0.020 |
Why?
|
| Biopsy | 1 | 1988 | 447 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 1998 | 625 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2006 | 163 | 0.020 |
Why?
|
| Retinaldehyde | 1 | 1985 | 1 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2007 | 156 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2006 | 87 | 0.010 |
Why?
|
| Oximes | 1 | 1985 | 11 | 0.010 |
Why?
|
| Retinoids | 1 | 1985 | 12 | 0.010 |
Why?
|
| Massachusetts | 1 | 2011 | 2094 | 0.010 |
Why?
|
| Forecasting | 1 | 2006 | 233 | 0.010 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 1985 | 22 | 0.010 |
Why?
|
| Skin Temperature | 1 | 2005 | 19 | 0.010 |
Why?
|
| Phospholipases | 1 | 1985 | 9 | 0.010 |
Why?
|
| Phospholipases A | 1 | 1985 | 15 | 0.010 |
Why?
|
| Peroxides | 1 | 1985 | 12 | 0.010 |
Why?
|
| Glutathione Peroxidase | 1 | 1985 | 29 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2005 | 110 | 0.010 |
Why?
|
| Sunflower Oil | 1 | 2004 | 5 | 0.010 |
Why?
|
| Olive Oil | 1 | 2004 | 7 | 0.010 |
Why?
|
| Phospholipids | 1 | 1985 | 82 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2005 | 249 | 0.010 |
Why?
|
| Aorta | 1 | 2004 | 110 | 0.010 |
Why?
|
| Aorta, Thoracic | 1 | 2004 | 77 | 0.010 |
Why?
|
| Dromaiidae | 1 | 2003 | 1 | 0.010 |
Why?
|
| Ear, External | 1 | 2003 | 6 | 0.010 |
Why?
|
| Administration, Topical | 1 | 2003 | 51 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2003 | 192 | 0.010 |
Why?
|
| Organ Size | 1 | 2003 | 169 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 1998 | 2176 | 0.010 |
Why?
|
| Double-Blind Method | 2 | 1999 | 744 | 0.010 |
Why?
|
| Amino Acids, Sulfur | 1 | 1982 | 1 | 0.010 |
Why?
|
| Chromium | 1 | 1982 | 5 | 0.010 |
Why?
|
| Vitamin E Deficiency | 1 | 1982 | 9 | 0.010 |
Why?
|
| Serum Amyloid A Protein | 1 | 2001 | 7 | 0.010 |
Why?
|
| Young Adult | 1 | 2012 | 4776 | 0.010 |
Why?
|
| ROC Curve | 1 | 2001 | 288 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 616 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2003 | 1019 | 0.010 |
Why?
|
| Scintillation Counting | 1 | 1999 | 2 | 0.010 |
Why?
|
| Erythrocyte Count | 1 | 1999 | 15 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1999 | 63 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 1999 | 73 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2009 | 2217 | 0.010 |
Why?
|
| Dinoprostone | 1 | 1999 | 43 | 0.010 |
Why?
|
| Seeds | 1 | 1999 | 32 | 0.010 |
Why?
|
| Respiration | 1 | 2000 | 92 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 1999 | 167 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 1998 | 52 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1999 | 245 | 0.010 |
Why?
|
| Glutathione Disulfide | 1 | 1998 | 2 | 0.010 |
Why?
|
| Simian virus 40 | 1 | 1998 | 17 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 1998 | 99 | 0.010 |
Why?
|
| Sulfhydryl Compounds | 1 | 1998 | 51 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1997 | 84 | 0.010 |
Why?
|
| Bangladesh | 1 | 1997 | 25 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1997 | 89 | 0.010 |
Why?
|
| Dihydrolipoamide Dehydrogenase | 1 | 1997 | 2 | 0.010 |
Why?
|
| Glutathione Reductase | 1 | 1997 | 5 | 0.010 |
Why?
|
| Abdomen | 1 | 1997 | 93 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1997 | 498 | 0.010 |
Why?
|
| Nitrogen Oxides | 1 | 1995 | 11 | 0.010 |
Why?
|
| Aldehydes | 1 | 1995 | 13 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1997 | 340 | 0.010 |
Why?
|
| Potentiometry | 1 | 1995 | 1 | 0.010 |
Why?
|
| Myocardium | 1 | 1997 | 288 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1996 | 460 | 0.010 |
Why?
|
| Malondialdehyde | 1 | 1993 | 16 | 0.010 |
Why?
|
| Uric Acid | 1 | 1993 | 47 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1995 | 404 | 0.010 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 1992 | 16 | 0.010 |
Why?
|
| Food Analysis | 1 | 1990 | 31 | 0.010 |
Why?
|
| Zea mays | 1 | 1990 | 30 | 0.010 |
Why?
|
| Cell Line | 1 | 1995 | 2055 | 0.010 |
Why?
|
| Species Specificity | 1 | 1991 | 334 | 0.010 |
Why?
|
| Pseudogenes | 1 | 1990 | 12 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1990 | 19 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1990 | 55 | 0.000 |
Why?
|
| Restriction Mapping | 1 | 1990 | 51 | 0.000 |
Why?
|
| Proteins | 1 | 1995 | 760 | 0.000 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1990 | 112 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1995 | 1019 | 0.000 |
Why?
|
| Molecular Structure | 1 | 1990 | 385 | 0.000 |
Why?
|
| Mice | 1 | 2003 | 11003 | 0.000 |
Why?
|
| Chromosome Mapping | 1 | 1990 | 290 | 0.000 |
Why?
|
| Brain | 1 | 1997 | 1581 | 0.000 |
Why?
|
| Base Sequence | 1 | 1990 | 1332 | 0.000 |
Why?
|
| Phenotype | 1 | 1991 | 1222 | 0.000 |
Why?
|
| Tocopherols | 1 | 1986 | 10 | 0.000 |
Why?
|
| Random Allocation | 1 | 1986 | 201 | 0.000 |
Why?
|
| Epithelium | 1 | 1985 | 96 | 0.000 |
Why?
|
| DNA | 1 | 1990 | 844 | 0.000 |
Why?
|
| Biological Availability | 1 | 1986 | 204 | 0.000 |
Why?
|
| Phospholipases A2 | 1 | 1985 | 15 | 0.000 |
Why?
|
| Colorimetry | 1 | 1985 | 26 | 0.000 |
Why?
|
| Pigment Epithelium of Eye | 1 | 1982 | 12 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1982 | 251 | 0.000 |
Why?
|